BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 28, 2002
View Archived Issues
Aventis presents two series of dopamine D3 modulators for schizophrenia and other CNS disorders
Read More
Positive phase I results for Prima BioMed's dendritic cell-based therapy
Read More
Risperidone positively affects behavioral and psychological symptoms of dementia
Read More
Cyclic peptides for use in the treatment of fungal infections and P. carinii pneumonia
Read More
Two phase III trials of Xyotax in PS2 NSCLC patients to proceed
Read More
New aldose reductase inhibitors in Sankyo development pipeline
Read More
Sumitomo researchers identify novel inhibitors of farnesoid X receptor transcription
Read More
Provigil study in shift work sleep disorder meets primary endpoints
Read More
Novel vitamin D analogues for calcium metabolic disorders covered by Chugai patent
Read More
Celltech designs novel alpha4 integrin antagonists
Read More
Androgen receptor modulators prepared and tested at Ligand
Read More
ALK-Abello and Schering-Plough to develop tablet-based allergy immunotherapy
Read More
GeneSoft acquires North American and European rights to Factive from LG Life Sciences
Read More
GW-433908 phase III program progresses
Read More
Patient randomization completed in phase II liver fibrosis trial of Actimmune
Read More
Pharmacopeia and Kowa form antiinflammatory research collaboration
Read More
Merck KGaA and Kos establish licensing agreement for Niaspan and Advicor
Read More
SBIR grant covers development of pancreatic cancer diagnostic test at Panacea
Read More
Antiangiogenic gene therapy enhances radiation-induced tumor vascular destruction
Read More
Garenoxacin compares favorably to ofloxacin in terms of chondrotoxicity
Read More
Inhibitor of iNOS dimerization shows oral activity in models of rheumatoid arthritis
Read More
Improved sensory thresholds reported for milnacipran in rats with spinal nerve injury
Read More
Potential use of spironolactone in rheumatoid arthritis
Read More
Reduction of serum urate levels reported for febuxostat in gout patients
Read More
Suppression of inflammation and joint destruction in RA by oral iNOS inhibitor
Read More
IDM and Nemod to develop cancer immunotherapy products
Read More
ABT-677 shows comparable efficacy to oseltamivir in mouse models of influenza
Read More